
    
      A total of 190 patients will be included in this trial, at 8-10 European sites.

      The primary endpoint is arterial healing at 6 month follow up. To assess the arterial
      healing, at 6 months follow-up all patients will undergo angiographic follow-up with OFDI
      investigation. To score the arterial healing, a Healing Score is used.
    
  